MX9706182A - Uso de acido hialuronico para el tratamiento de cistitis intersticial. - Google Patents
Uso de acido hialuronico para el tratamiento de cistitis intersticial.Info
- Publication number
- MX9706182A MX9706182A MX9706182A MX9706182A MX9706182A MX 9706182 A MX9706182 A MX 9706182A MX 9706182 A MX9706182 A MX 9706182A MX 9706182 A MX9706182 A MX 9706182A MX 9706182 A MX9706182 A MX 9706182A
- Authority
- MX
- Mexico
- Prior art keywords
- interstitial cystitis
- hyaluronic acid
- treatment
- cystitis
- daltons
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
Un método de tratamiento que comprende poner en contacto a la vejiga interna y a las estructuras asociadas en un mamífero que tiene cistitis intersticial, con una solucion que contiene ácido hialuronico que tiene un peso molecular promedio no menor a 2 x 10-6 Daltons en una concentracion efectiva para tratar la cistitis intersticial.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/388,038 US5591724A (en) | 1995-02-14 | 1995-02-14 | Method for treating the urinary bladder and associated structures using hyaluronic acid |
US08388038 | 1995-02-14 | ||
US59101596A | 1996-02-08 | 1996-02-08 | |
US591,015 | 1996-02-08 | ||
US591015 | 1996-02-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9706182A true MX9706182A (es) | 1998-07-31 |
MXPA97006182A MXPA97006182A (es) | 1998-11-09 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
NO973732D0 (no) | 1997-08-13 |
JPH10513476A (ja) | 1998-12-22 |
CZ257497A3 (cs) | 1998-01-14 |
KR19980702251A (ko) | 1998-07-15 |
JP4354528B2 (ja) | 2009-10-28 |
PT813417E (pt) | 2003-12-31 |
HUP9800467A3 (en) | 1999-01-28 |
IN181358B (es) | 1998-05-30 |
CN1181016A (zh) | 1998-05-06 |
KR100268660B1 (ko) | 2000-10-16 |
EP0813417B1 (en) | 2003-08-20 |
NO973732L (no) | 1997-10-10 |
DE69629553T2 (de) | 2004-06-17 |
CA2203621C (en) | 1998-04-28 |
WO1996025168A1 (en) | 1996-08-22 |
ATE247476T1 (de) | 2003-09-15 |
AU705289B2 (en) | 1999-05-20 |
NO315842B1 (no) | 2003-11-03 |
CA2203621A1 (en) | 1996-08-22 |
HUP9800467A2 (hu) | 1998-06-29 |
EP0813417A1 (en) | 1997-12-29 |
TR199700782T1 (xx) | 1998-03-21 |
DK0813417T3 (da) | 2003-11-03 |
DE69629553D1 (de) | 2003-09-25 |
ES2205013T3 (es) | 2004-05-01 |
US5888986A (en) | 1999-03-30 |
NZ300903A (en) | 1999-07-29 |
CZ288218B6 (en) | 2001-05-16 |
BR9607601A (pt) | 1999-09-14 |
AU4617996A (en) | 1996-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ300903A (en) | Use of hyaluronic acid having an mr of not less than 20000 daltons for the treatment of cystitis | |
ZA988278B (en) | Ionic polymers as toxin-binding agents | |
WO1995017154A3 (en) | Use of thalidomide for treating neurocognitive disorders | |
UA32429C2 (uk) | Засіб для лікування нетримання сечі | |
EP0802782A4 (en) | PROPHYLACTIC AND THERAPEUTIC TREATMENT OF MAIN SENSITIZATION AND IRRITATION | |
CA2194976A1 (en) | Wound healing agent | |
PL338705A1 (en) | Application of gaba analogues in preventing and treating gastrointestinal diseases | |
RU93052390A (ru) | Способ лечения шизофрении, применение комбинации арахидоновой и докозагексановой кислот для получения лекарственного средства для лечения шизофрении | |
PT646012E (pt) | Cura de feridas e tratamento de perturbacoes fibroticas por tgfbeta-3 | |
WO2002056895A3 (en) | Ionene polymers and their use in treating mucositis | |
BR8907770A (pt) | Solucao para tratamento de metal,solucao aquosa e processo para tratar uma superficie de metal | |
PT981115E (pt) | Metodo para a execucao de um programa de codificacao para a codificacao de dados num suporte de dados portatil com microprocessador | |
EP0358386A3 (en) | Method for the treatment of wool | |
PL328959A1 (en) | Method of treating or preventing interstitial cystitis | |
AU4148693A (en) | Product and process for treating bovine mastitis and bovine metritis | |
NZ512086A (en) | Method of increasing fat firmness and improving meat quality in animals | |
EP1007093A4 (en) | METHODS OF TREATING DISORDERS WITH INTERLEUKIN-9 AND ITS ANTAGONISTS | |
DE69818809D1 (de) | Verfahren zur behandlung von narbengewebe | |
ATE225181T1 (de) | Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen | |
UA6506A (uk) | Спосіб прогнозування ефективності імунодепресивної терапії у дітей з нефротичною формою гломерулонефриту | |
MX9700626A (es) | USO DE AZASPIRANOS EN LA REPARACIaN DE COMPOSICIONES PARA TRATAR INFECCIONES OPORTUNISTAS. | |
刘世忠 | THE EFFECT OF AURICULAR-PLASTER THERAPY ON 1000 CASES OF DYSMENORRHEA | |
UA28207A (uk) | Спосіб лікування черепно-мозкової травми | |
张和平 | DEEP INSERTION OF THE NEEDLE ATYAOYANGGUAN WITH ELECTROSTIMULATION FOR TREATMENT OF 120 CASES OF SCIATICA | |
IT1248026B (it) | Composizione di trattamento di acque di rifiuto da destinare al riciclo,e procedimento di riciclo di acque di rifiuto che utilizza questa composizione. |